Yu-Waye Chu - Dec 10, 2021 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
Senior VP Clinical Development
Signature
/s/ Cindy Tahl, as Attorney-in-Fact
Stock symbol
FATE
Transactions as of
Dec 10, 2021
Transactions value $
-$263,548
Form type
4
Date filed
12/13/2021, 04:53 PM
Previous filing
Nov 22, 2021
Next filing
Jan 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Options Exercise $122K +7.5K +5.96% $16.32 133K Dec 10, 2021 Direct F1
transaction FATE Common Stock Sale -$103K -2.1K -1.57% $49.32* 131K Dec 10, 2021 Direct F1, F2
transaction FATE Common Stock Sale -$45.4K -900 -0.69% $50.42* 130K Dec 10, 2021 Direct F1, F3
transaction FATE Common Stock Sale -$53.4K -1.05K -0.8% $51.08* 129K Dec 10, 2021 Direct F1, F4
transaction FATE Common Stock Sale -$95.4K -1.82K -1.41% $52.37* 127K Dec 10, 2021 Direct F1, F5
transaction FATE Common Stock Sale -$55.3K -1.03K -0.81% $53.66* 126K Dec 10, 2021 Direct F1, F6
transaction FATE Common Stock Sale -$32.7K -600 -0.47% $54.58* 127K Dec 10, 2021 Direct F1, F7
transaction FATE Common Stock Sale -$278 -5 0% $55.54* 126K Dec 10, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -7.5K -6.67% $0.00 105K Dec 10, 2021 Common Stock 7.5K $16.32 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020.
F2 Represents the weighted average sale price of the shares sold ranging from $48.95 to $49.87 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 7.
F3 Represents the weighted average sale price of the shares sold ranging from $49.96 to $50.89 per share.
F4 Represents the weighted average sale price of the shares sold ranging from $50.96 to $51.22 per share.
F5 Represents the weighted average sale price of the shares sold ranging from $52.09 to $52.87 per share.
F6 Represents the weighted average sale price of the shares sold ranging from $53.10 to $54.02 per share.
F7 Represents the weighted average sale price of the shares sold ranging from $54.33 to $54.98 per share.
F8 The option shall vest as to 25% of the underlying shares on April 15, 2020 and thereafter on a monthly basis for 36 additional months, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date